These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 28771182)

  • 1. New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis.
    Yang AC; Tsai SJ
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathology of schizophrenia].
    Uezato A; Nishikawa T
    Nihon Rinsho; 2013 Apr; 71(4):591-8. PubMed ID: 23678584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.
    Carlsson A; Hansson LO; Waters N; Carlsson ML
    Life Sci; 1997; 61(2):75-94. PubMed ID: 9217267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.
    Kim YK; Choi J; Park SC
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy.
    Oh SJ; Fan X
    CNS Drugs; 2019 Jun; 33(6):539-547. PubMed ID: 30993607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance.
    Howes OD; Shatalina E
    Biol Psychiatry; 2022 Sep; 92(6):501-513. PubMed ID: 36008036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter systems in schizophrenia.
    Reynolds GP
    Int Rev Neurobiol; 1995; 38():305-39. PubMed ID: 8537203
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.
    Bencherif M; Stachowiak MK; Kucinski AJ; Lippiello PM
    Med Hypotheses; 2012 May; 78(5):594-600. PubMed ID: 22336089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
    Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML
    Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the dopamine hypothesis explain schizophrenia?
    Lau CI; Wang HC; Hsu JL; Liu ME
    Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques].
    Szekeres G; Pávics L; Janka Z
    Ideggyogy Sz; 2002 Jul; 55(7-8):226-32. PubMed ID: 12201230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate.
    Stahl SM
    CNS Spectr; 2018 Jun; 23(3):187-191. PubMed ID: 29954475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
    Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
    Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.
    Sonnenschein SF; Grace A
    Expert Opin Ther Targets; 2021 Jan; 25(1):15-26. PubMed ID: 33170748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.